BRPI0410239A - composto de 4-(2-furoil)aminopiperidina e medicamento - Google Patents

composto de 4-(2-furoil)aminopiperidina e medicamento

Info

Publication number
BRPI0410239A
BRPI0410239A BRPI0410239-8A BRPI0410239A BRPI0410239A BR PI0410239 A BRPI0410239 A BR PI0410239A BR PI0410239 A BRPI0410239 A BR PI0410239A BR PI0410239 A BRPI0410239 A BR PI0410239A
Authority
BR
Brazil
Prior art keywords
pyridylmethyl
mesityl
alkyl
following general
caused
Prior art date
Application number
BRPI0410239-8A
Other languages
English (en)
Inventor
Yukiko Muraki
Tomokazu Fujimoto
Takuya Kishimoto
Original Assignee
Kyorin Seiyaku Kk
Nisshin Seifun Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk, Nisshin Seifun Group Inc filed Critical Kyorin Seiyaku Kk
Publication of BRPI0410239A publication Critical patent/BRPI0410239A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"COMPOSTO DE 4-(2-FUROIL)AMINOPIPERIDINA E MEDICAMENTO". A invenção refere-se a compostos representados pela seguinte fórmula geral (I): ¢na qual R¬ 1¬ é 5-metilpiridin-2-ila, p-tolila ou mesitila, R¬ 2¬ é uma das seguintes fórmulas gerais (II) - (IX): (nas quais R¬ 3¬ é C1-C4-alquila, R¬ 4¬ é H ou C1-C4-alquila, R¬ 5¬ é H, 3-piridilmetila ou 4-piridilmetila, e R¬ 6¬ é 2,4-dihidroxibenzila, 3-piridilmetila ou 4-piridilmetil), ou quando R¬ 1¬ é mesitila, R¬ 2¬ é a seguinte fórmula (X)!, e sais farmaceuticamente aceitáveis dos mesmos. Os compostos apresentam ação inibidora de prurido, e são úteis para prevenção ou tratamento de coceira e prurido causado por reação contra ferimentos causados por insetos, reação contra agentes alergênicos do ambiente, infecções de pele ou infecções de parasitas externos, ou causadas a pacientes de diálise renal.
BRPI0410239-8A 2003-05-08 2004-05-06 composto de 4-(2-furoil)aminopiperidina e medicamento BRPI0410239A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003130634 2003-05-08
PCT/JP2004/006421 WO2004099194A1 (ja) 2003-05-08 2004-05-06 掻痒治療薬として有用な４－（２－フロイル）アミノピペリジン類

Publications (1)

Publication Number Publication Date
BRPI0410239A true BRPI0410239A (pt) 2006-05-16

Family

ID=33432110

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0410239-8A BRPI0410239A (pt) 2003-05-08 2004-05-06 composto de 4-(2-furoil)aminopiperidina e medicamento

Country Status (9)

Country Link
US (1) US7601843B2 (pt)
EP (2) EP2325183A1 (pt)
JP (1) JP4009303B2 (pt)
KR (1) KR101160858B1 (pt)
CN (1) CN100582103C (pt)
BR (1) BRPI0410239A (pt)
CA (1) CA2524498C (pt)
MX (1) MXPA05012007A (pt)
WO (1) WO2004099194A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
US7842616B2 (en) * 2007-01-22 2010-11-30 Advanced Technology Development Facility, Inc. Methods for fabricating semiconductor structures
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
MX2009011416A (es) 2007-04-23 2009-11-05 Janssen Pharmaceutica Nv Tia(di)azoles como antagonistas del receptor de dopamina 2 de disociacion rapida.
RS52518B (sr) 2007-04-23 2013-04-30 Janssen Pharmaceutica N.V. Derivati 4-alkoksipiridazina kao brzo disocirajući dopamin 2 receptorski antagonisti
US20100137368A1 (en) * 2007-04-23 2010-06-03 Janssen Pharmaceutica N.V. Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
CA2729313C (en) 2008-07-03 2016-08-30 Janssen Pharmaceutica Nv Substituted 6-(1-piperazinyl)-pyridazines as 5-ht6 receptor antagonists
ES2622161T3 (es) 2008-07-31 2017-07-05 Janssen Pharmaceutica, N.V. Piridinas sustituidas con piperazin-1-il-trifluorometilo como antagonistas del receptor de la dopamina 2 de disociación rápida

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4584303A (en) * 1984-04-09 1986-04-22 The Boc Group, Inc. N-aryl-N-(4-piperidinyl)amides and pharmaceutical compositions and method employing such compounds
US4667773A (en) * 1986-06-27 1987-05-26 Tonnie Davis Portable tree stand
US4791112A (en) * 1987-02-02 1988-12-13 The Boc Group, Inc. N-heterocyclic-N-(4-piperidyl)amides and pharmaceutical compositions and methods employing such compounds
US5567773A (en) 1995-04-04 1996-10-22 Mobil Oil Corporation Cold sealable cohesive polymers
US5888494A (en) 1996-03-12 1999-03-30 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith
US5667773A (en) 1996-03-12 1997-09-16 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic conditions therewith
US5811078A (en) 1997-03-14 1998-09-22 Adolor Corporation Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions therewith
US5798093A (en) 1997-03-14 1998-08-25 Adolor Corporation Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith
GB9912417D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
EP1443046B1 (en) 2001-10-09 2008-12-17 Kyorin Pharmaceutical Co., Ltd. Novel 4-(2furoyl)aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same

Also Published As

Publication number Publication date
EP2325183A1 (en) 2011-05-25
WO2004099194A1 (ja) 2004-11-18
US7601843B2 (en) 2009-10-13
US20060270632A1 (en) 2006-11-30
CA2524498A1 (en) 2004-11-18
CA2524498C (en) 2012-01-24
EP1621538A1 (en) 2006-02-01
CN1784398A (zh) 2006-06-07
JP4009303B2 (ja) 2007-11-14
KR101160858B1 (ko) 2012-07-02
CN100582103C (zh) 2010-01-20
KR20060014039A (ko) 2006-02-14
EP1621538A4 (en) 2009-07-29
MXPA05012007A (es) 2006-05-31
JPWO2004099194A1 (ja) 2006-07-13

Similar Documents

Publication Publication Date Title
BR0215777A (pt) Composto, método para preparar o mesmo, composição farmacêutica para prevenir e tratar cardioisquemia, cerebroisquemia, oclusão arterial cerebral e para melhorar microcirculação do cérebro, e uso do composto
NO20081482L (no) Delta- og epsilon-krystallformer for imatinibmesylat
BR0316264A (pt) Medicamento para tratamento de doença pulmonar obstrutiva crÈnica
BR122020005056A8 (pt) Método para preparar uma preparação oral que compreende cloridrato de n-[4-[4-(1,2-benziso-tiazol-3-il)-1-piperazinil]-(2r,3r)-2,3-tetrametileno-butil]-(1’r,2’s,3’r,4’s)-2,3-biciclo[2,2,1]heptanodicarboxiimida (lurasidona)
BR0307291A (pt) Composto; processo para a preparação de um composto; composição farmacêutica; uso de um composto; método para o tratamento e profilaxia de distúrbios diversos e de obesidade em um humano
BRPI0410979A (pt) composto, composição farmacêutica, e, métodos para tratar uma doença em um animal mediada pela catepsina s e para tratar um paciente submetido a uma terapia
BR0210384A (pt) Heteroarilas multicìclicas substituìdas por quinuclidinas para o tratamento de doença
BRPI0409109A (pt) novos compostos
EA200401114A2 (ru) Замещённые гидроксиэтиламины
BR0207910A (pt) HidantÈnios e sua utilização no tratamento do diabetes
BR0309083A (pt) Compostos derivados de benzoxazinona, sua preparação e uso como medicamentos
BRPI0410239A (pt) composto de 4-(2-furoil)aminopiperidina e medicamento
BR0109816A (pt) Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, métodos para o tratamento da dor, papa o tratamento de distúrbios gastrointestinais, e para o tratamento de lesões espinhais
BRPI0409110A (pt) derivados de 4-(4-heterociclilalcoxi)fenil-1-(heterociclil-carboni l)piridina e compostos relacionados como antagonistas de histamina h3 para o tratamento de doenças neurológicas tais como alzheimer
BR9910179A (pt) Composto, composição farmacêutica, uso de um composto, e, processo para tratar uma doença ou condição mediada por fator xa em um animal de sangue quente
RU2003103780A (ru) Соединения фенилпиридазина и содержащие их лекарственные средства
SE9903894D0 (sv) Novel compounds
DE69429328D1 (de) N-(3-piperidinylcarbonyl)-b-alanin derivate als paf-antagonisten
BRPI0408689A (pt) derivados de benzenosulfonamida, método para preparação e utilização disso para o tratamento da dor
RU2014112324A (ru) Применение органического соединения для лечения синдрома нунан
BRPI0416238A (pt) compostos, processo para a sua preparação, composição farmacêutica que compreende os mesmos, uso dos compostos e métodos para o tratamento e/ou a prevenção de doenças que são moduladas por ppar(delta) e/ou agonistas ppar(alfa)
WO2002064552A8 (en) 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES
BRPI0507757A (pt) composto, composição farmacêutica, e agente terapêutico para uma doença na qual a angiogênese ou a hipermeabilidade vascular está envolvida
DE602005018390D1 (de) Verwendung von thiazolidinon-derivaten zur behandlung von festen tumoren
BRPI0412860A (pt) derivados de 2-[4-(2-hidroximetil-fenilamino)-piperidin-1-il]-n-(9h-ca rbazol-3-il)- acetamida e compostos relacionados como ligantes do neuropeptìdeo y5 (npy5) para o tratamento de obesidade

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2259 DE 22/04/2014.